Immunohistochemical assay (IHC) involves applying five specific monoclonal antibodies against five different protein antigens (markers) to a single tissue slide. It is used to improve histological classification, simultaneously evaluate a wider range of therapeutic and prognostic indicators, and differentiate between tumors with similar patterns.